{
    "clinical_study": {
        "@rank": "129333", 
        "acronym": "PULSE-A", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention"
            }, 
            {
                "arm_group_label": "Metformin", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Dietary Restriction", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Exercise", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to test in 52 overweight and obese women with polycystic ovary\n      syndrome the effect of 6 months of treatment with either: exercise training, 25% dietary\n      restriction or metformin in comparison to a control group receiving no intervention on the\n      functions of the skeletal muscle and adipose tissue."
        }, 
        "brief_title": "Effect of Weight and Insulin Sensitivity on Reproductive Function in Polycystic Ovary Syndrome:Studies in Skeletal Muscle and Adipose Tissue", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Polycystic Ovary Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Polycystic Ovary Syndrome", 
                "Insulin Resistance"
            ]
        }, 
        "detailed_description": {
            "textblock": "The PULSE Ancillary study will last about 7 months. Participants will one or two additional\n      procedures performed at baseline and during the week 24 testing.\n\n      These procedures include a fat biopsy, a muscle biopsy or both."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Enrolled in PULSE\n\n        Exclusion Criteria:\n\n          -  Withdraw from PULSE"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "52", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01775176", 
            "org_study_id": "PBRC11016-A"
        }, 
        "intervention": [
            {
                "arm_group_label": "Metformin", 
                "intervention_name": "Metformin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Exercise", 
                "intervention_name": "Exercise", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Dietary Restriction", 
                "intervention_name": "Dietary Restriction", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Insulin", 
                "Metformin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "PCOS, Weight, Insulin Sensitivity, Reproductive Function", 
        "lastchanged_date": "November 27, 2013", 
        "location": {
            "contact": {
                "email": "erin.lejeune@pbrc.edu", 
                "last_name": "Erin Lejeune, B.S.", 
                "phone": "225-763-2706"
            }, 
            "facility": {
                "address": {
                    "city": "Baton Rouge", 
                    "country": "United States", 
                    "state": "Louisiana", 
                    "zip": "70808"
                }, 
                "name": "Pennington Biomedical Research Center"
            }, 
            "investigator": {
                "last_name": "Leanne M Redman, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effect of Weight and Insulin Sensitivity on Reproductive Function in Polycystic Ovary Syndrome: Studies in Skeletal Muscle and Adipose Tissue 'PULSE Ancillary Study'", 
        "overall_contact": {
            "email": "erin.lejeune@pbrc.edu", 
            "last_name": "Erin Lejeune, B.S.", 
            "phone": "225-763-2706"
        }, 
        "overall_official": {
            "affiliation": "Pennington Biomedical Research Center", 
            "last_name": "Leanne M Redman, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Change in skeletal muscle insulin resistance   Pulsatility profile of Luteinizing Hormone (LH)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 24"
            }, 
            {
                "measure": "Change in adipose tissue insulin resistance", 
                "safety_issue": "No", 
                "time_frame": "Baseline,  week 24"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01775176"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Pennington Biomedical Research Center", 
            "investigator_full_name": "Leanne Redman", 
            "investigator_title": "Principle Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Pennington Biomedical Research Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pennington Biomedical Research Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}